cardiovascular diseases

News

iRhythm wearable heart monitor raises AFib diagnoses by 52%

Screening people in primary care with a wearable heart monitor developed by iRhythm was able to increase diagnoses of atrial fibrillation (AFib) by 52%, although it did not result in a redu

News

Kerendia works in heart failure, but how might it be used?

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure in the FINEARTS-HF study, setting up regulatory approvals, but th

News

Novartis builds case for Leqvio with monotherapy data

Novartis has a long way to go to make its twice-yearly cholesterol-lowering drug Leqvio the multi-billion-dollar blockbuster it is predicting – but took another step along that road today.

News

AI voice assistant can spot complications in heart patients

A virtual voice assistant that calls patients after heart procedures can allow them to be discharged from hospital earlier and identify patients who may need follow-up interventions, accord

News

Judge rebuffs Novartis bid to block generic Entresto

A judge in the US has denied an attempt by Novartis to stop MSN Pharmaceuticals from launching a generic version of heart failure blockbuster Entresto.

News

Bayer's finerenone clears key heart failure trial

At the start of this year, Bayer said there were two important trial readouts for the company to deliver near-term growth this year as it rebuilds its pipeline – and both have now delivered

iRhythm wearable heart monitor raises AFib diagnoses by 52%

Kerendia works in heart failure, but how might it be used?

Novartis builds case for Leqvio with monotherapy data

AI voice assistant can spot complications in heart patients

Judge rebuffs Novartis bid to block generic Entresto

Bayer's finerenone clears key heart failure trial

NHS use of digital cardiac rehab tools endorsed

How to meet your physicians where they are online

cardiovascular diseases

Editor's Picks